R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25

Journal of Comparative Effectiveness Research 2026 Open access

Read full text
Authors: Paul Arora, Sreeram V Ramagopalan
DOI: 10.57264/cer-2026-0073
Cited by: 1
References: 17

Abstract

In this update, we discuss the use of real-world data in the Haute Autorité de Santé assessment of economic evaluations, review how real-world evidence is supporting regulatory approvals in multiple myeloma, and consider lessons from the failed EVOKE trials of semaglutide in Alzheimer's disease for the broader application of target trial emulation.

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Pharmaceutical Economics and Policy Statistical Methods in Clinical Trials

Publication details

Journal / source
Journal of Comparative Effectiveness Research
Publisher
Becaris Publishing Limited
Volume
15
Issue
6
Pages
e260073–e260073
Publication date
16 April 2026
Language
EN